Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized dosing of aminoglycosides, quinolones and glycopeptide antibiotics in obese patients
2015-004814-84Phase 4Completed
- Sponsor
- St. Antonius Ziekenhuis
- Start
- May 2016
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of gentamicin, tobramycin, vancomycin and ciprofloxacin in bacterial disease (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoints: Clearance of study antibiotics, Volume of distribution and 1 more. Started May 2016; status: completed.
02
Drugs
gentamicintobramycinvancomycinciprofloxacin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2015-004814-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004814-84.